19 diciembre 2011

Yondelis Fase III Sarcoma . Actualización del Ensayo iniciado en 2005 por Johnson & Johnson Pharmaceutical Research & Development, L.L.C .

Descriptive Information .

Brief title :

A Study to Provide Access to Trabectedin in Patients With Non L-type Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care Treatment

Official title :

A Multicenter, Open-Label Single-Arm Study of YONDELIS (Trabectedin) for Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma Excluding Leiomyosarcoma and Liposarcoma Who Have Relapsed or Are Refractory to Standard of Care Treatment

...